It is a bit of a cliche by now to say that the Covid-19 pandemic and its aftershocks were unprecedented, that we are still bearing the adverse health and socioeconomic outcomes, even as we attempt to live in a world endemic with the SARS-CoV-2 virus.
It has also been said that the crisis has highlighted the importance of having a robust healthcare system – one that will not only be able to withstand future infectious disease outbreaks, but is also fit-for-purpose as we deal with ever- increasing non-communicable diseases (NCDs) and escalating healthcare-related costs.